TENAX THERAPEUTICS, INC. - TENX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Sep 08, 2026 | SCHEDULE 13G | ADAR1 Capital Management, LLC | 14.0% | 5,257,389 | View |
| Sep 08, 2026 | SCHEDULE 13G | Daniel Schneeberger | 14.0% | 5,257,389 | View |
| Sep 08, 2026 | SCHEDULE 13G/A | FMR LLC | 1.4% | 514,925 | View |
| Sep 08, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 1.4% | 514,925 | View |
| Aug 27, 2026 | SCHEDULE 13G | — | — | — | View |
| Aug 27, 2026 | SCHEDULE 13G | — | — | — | View |
| Aug 18, 2026 | SCHEDULE 13G | Millennium Management LLC | 5.8% | 2,156,891 | View |
| Aug 18, 2026 | SCHEDULE 13G | Millennium Group Management LLC | 5.8% | 2,156,891 | View |
| Aug 18, 2026 | SCHEDULE 13G | Israel A. Englander | 5.8% | 2,156,891 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Ikarian Capital, LLC | 2.9% | 1,080,700 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Neil Shahrestani | 2.9% | 1,080,700 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Perceptive Advisors LLC | 4.5% | 1,700,000 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Joseph Edelman | 4.5% | 1,700,000 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Perceptive Life Sciences Master Fund, Ltd. | 4.5% | 1,700,000 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners III, L.P. | 4.7% | 1,574,892 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | VHCP Co-Investment Holdings III, LLC | 4.7% | 1,574,892 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners EG, L.P. | 4.7% | 1,574,892 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | VHCP Management III, LLC | 4.7% | 1,574,892 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | VHCP Management EG, LLC | 4.7% | 1,574,892 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Nimish Shah | 4.7% | 1,574,892 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Bong Y. Koh | 4.7% | 1,574,892 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND L P | 9.5% | 2,966,661 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BVF I GP LLC | 9.5% | 2,966,661 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND II LP | 0.5% | 141,570 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BVF II GP LLC | 0.5% | 141,570 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Biotechnology Value Trading Fund OS LP | 0.0% | 7 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BVF Partners OS Ltd. | 0.0% | 7 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BVF GP HOLDINGS LLC | 9.98% | 3,108,231 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BVF PARTNERS L P/IL | 9.99% | 3,110,363 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | BVF INC/IL | 9.99% | 3,110,363 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | LAMPERT MARK N | 9.99% | 3,110,363 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Vivo Opportunity Fund Holdings, L.P. | 9.0% | 3,458,327 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Vivo Opportunity, LLC | 9.0% | 3,458,327 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | RTW Investments, LP | 9.9% | 2,866,654 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Roderick Wong | 9.9% | 2,866,654 | View |
| Aug 12, 2026 | SCHEDULE 13G/A | Adage Capital Management, L.P. | 6.81% | 1,899,495 | View |
| Aug 12, 2026 | SCHEDULE 13G/A | Robert Atchinson | 6.81% | 1,899,495 | View |
| Aug 12, 2026 | SCHEDULE 13G/A | Phillip Gross | 6.81% | 1,899,495 | View |
| Jul 31, 2026 | SCHEDULE 13D/A | — | 4.32% | — | View |
| Jul 30, 2026 | SCHEDULE 13G | BlackRock, Inc. | 6.4% | 1,708,335 | View |
| Jul 17, 2026 | SCHEDULE 13G/A | Millennium Management LLC | 3.3% | 876,230 | View |
| Jul 17, 2026 | SCHEDULE 13G/A | Millennium Group Management LLC | 3.3% | 876,230 | View |
| Jul 17, 2026 | SCHEDULE 13G/A | Israel A. Englander | 3.3% | 876,230 | View |
| Jul 08, 2026 | SCHEDULE 13G | FMR LLC | 14.9% | 3,942,373 | View |
| Jul 08, 2026 | SCHEDULE 13G | Abigail P. Johnson | 14.9% | 3,942,373 | View |
| Jun 05, 2026 | SCHEDULE 13G/A | T. Rowe Price Associates, Inc. | 2.2% | 586,990 | View |
| May 20, 2026 | SCHEDULE 13G | Millennium Management LLC | 5.1% | 1,347,130 | View |
| May 20, 2026 | SCHEDULE 13G | Millennium Group Management LLC | 5.1% | 1,347,130 | View |
| May 20, 2026 | SCHEDULE 13G | Israel A. Englander | 5.1% | 1,347,130 | View |
| May 15, 2026 | SCHEDULE 13G/A | Logos Global Management LP | 3.0% | 800,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Logos Global Management GP LLC | 3.0% | 800,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Logos Global Master Fund LP | 3.0% | 800,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Logos GP LLC | 3.0% | 800,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Arsani William | 3.0% | 800,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Stonepine Capital Management, LLC | 3.7% | 975,200 | View |
| May 15, 2026 | SCHEDULE 13G/A | Stonepine Capital, L.P. | 3.7% | 975,200 | View |
| May 15, 2026 | SCHEDULE 13G/A | Stonepine GP, LLC | 3.7% | 975,200 | View |
| May 15, 2026 | SCHEDULE 13G/A | Jon M. Plexico | 3.7% | 975,200 | View |
| May 15, 2026 | SCHEDULE 13G/A | Lind Global Fund II LP | 0.78% | 202,480 | View |
| May 15, 2026 | SCHEDULE 13G/A | Lind Global Partners II LLC | 0.78% | 202,480 | View |
| May 15, 2026 | SCHEDULE 13G/A | EASTON JEFF | 0.78% | 202,480 | View |
| May 15, 2026 | SCHEDULE 13G/A | Perceptive Advisors LLC | 5.5% | 1,447,782 | View |
| May 15, 2026 | SCHEDULE 13G/A | Joseph Edelman | 5.5% | 1,447,782 | View |
| May 15, 2026 | SCHEDULE 13G/A | Perceptive Life Sciences Master Fund, Ltd. | 5.5% | 1,447,782 | View |
| May 15, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners III, L.P. | 9.9% | 1,955,105 | View |
| May 15, 2026 | SCHEDULE 13G/A | VHCP Co-Investment Holdings III, LLC | 9.9% | 1,955,105 | View |
| May 15, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners EG, L.P. | 9.9% | 1,955,105 | View |
| May 15, 2026 | SCHEDULE 13G/A | VHCP Management III, LLC | 9.9% | 1,955,105 | View |
| May 15, 2026 | SCHEDULE 13G/A | VHCP Management EG, LLC | 9.9% | 1,955,105 | View |
| May 15, 2026 | SCHEDULE 13G/A | Nimish Shah | 9.9% | 1,955,105 | View |
| May 15, 2026 | SCHEDULE 13G/A | Bong Y. Koh | 9.9% | 1,955,105 | View |
| May 15, 2026 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND L P | 9.2% | 1,754,719 | View |
| May 15, 2026 | SCHEDULE 13G/A | BVF I GP LLC | 9.2% | 1,754,719 | View |
| May 15, 2026 | SCHEDULE 13G/A | BIOTECHNOLOGY VALUE FUND II LP | 0.9% | 149,536 | View |
| May 15, 2026 | SCHEDULE 13G/A | BVF II GP LLC | 0.9% | 149,536 | View |
| May 15, 2026 | SCHEDULE 13G/A | Biotechnology Value Trading Fund OS LP | 0.0% | 0 | View |
| May 15, 2026 | SCHEDULE 13G/A | BVF Partners OS Ltd. | 0.0% | 0 | View |
| May 15, 2026 | SCHEDULE 13G/A | BVF GP HOLDINGS LLC | 9.97% | 1,904,255 | View |
| May 15, 2026 | SCHEDULE 13G/A | BVF PARTNERS L P/IL | 9.99% | 1,908,722 | View |
| May 15, 2026 | SCHEDULE 13G/A | BVF INC/IL | 9.99% | 1,908,722 | View |
| May 15, 2026 | SCHEDULE 13G/A | LAMPERT MARK N | 9.99% | 1,908,722 | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 3.1% | 533,965 | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 3.1% | 533,965 | View |
| May 15, 2026 | SCHEDULE 13G/A | Steven A. Cohen | 3.1% | 533,965 | View |
| May 15, 2026 | SCHEDULE 13G/A | Dellora Investments Master Fund LP | 2.0% | 345,257 | View |
| May 15, 2026 | SCHEDULE 13G/A | Dellora Investments LP | 2.3% | 394,665 | View |
| May 15, 2026 | SCHEDULE 13G/A | Kevin Pyun | 2.3% | 394,665 | View |
| May 15, 2026 | SCHEDULE 13G/A | RTW Investments, LP | 9.9% | 1,867,630 | View |
| May 15, 2026 | SCHEDULE 13G/A | Roderick Wong | 9.9% | 1,867,630 | View |
| May 08, 2026 | SCHEDULE 13G/A | Integrated Core Strategies (US) LLC | 1.7% | 448,475 | View |
| May 08, 2026 | SCHEDULE 13G/A | Millennium Management LLC | 2.1% | 533,889 | View |
| May 08, 2026 | SCHEDULE 13G/A | Millennium Group Management LLC | 2.1% | 533,889 | View |
| May 08, 2026 | SCHEDULE 13G/A | Israel A. Englander | 2.1% | 533,889 | View |
| May 07, 2026 | SCHEDULE 13G/A | T. Rowe Price Associates, Inc. | 17.2% | 2,951,116 | View |
| May 07, 2026 | SCHEDULE 13G/A | T. Rowe Price Associates, Inc. | 11.0% | 2,841,114 | View |
| May 04, 2026 | SCHEDULE 13G/A | Invus Public Equities, L.P. | 2.1% | 366,143 | View |
| May 04, 2026 | SCHEDULE 13G/A | Invus Public Equities Advisors, LLC | 2.1% | 366,143 | View |
| May 04, 2026 | SCHEDULE 13G/A | Invus Global Management, LLC | 2.1% | 366,143 | View |
| May 04, 2026 | SCHEDULE 13G/A | Siren, L.L.C. | 2.1% | 366,143 | View |
| May 04, 2026 | SCHEDULE 13G/A | Avicenna Life Sci Master Fund LP | 0.4% | 60,998 | View |
| May 04, 2026 | SCHEDULE 13G/A | Avicenna Life Sci Master GP LLC | 0.4% | 60,998 | View |
| May 04, 2026 | SCHEDULE 13G/A | Ulys, L.L.C. | 0.4% | 60,998 | View |
| May 04, 2026 | SCHEDULE 13G/A | Raymond Debbane | 2.5% | 427,141 | View |
| Apr 08, 2026 | SCHEDULE 13G/A | Morgan Stanley | 3.5% | 596,564 | View |
| Apr 08, 2026 | SCHEDULE 13G/A | Morgan Stanley Capital Services LLC | 3.4% | 583,297 | View |
| Apr 07, 2026 | SCHEDULE 13G/A | Ikarian Capital, LLC | 6.7% | 1,145,100 | View |
| Apr 07, 2026 | SCHEDULE 13G/A | Neil Shahrestani | 6.7% | 1,145,100 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.